Dr. Liza Smirnoff, MD

Dr. Smirnoff practices at UMiami Medicine - Neurology in Miami, Florida.

Dr. Smirnoff's NPI, 1326492224, was assigned on April 17, 2016. Dr. Smirnoff graduated from FIU Herbert Wertheim College of Medicine in 2016. Dr. Smirnoff holds Florida license ME159123.

Dr. Smirnoff's primary practice is UMiami Medicine - Neurology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-4951.

Dr. Smirnoff's primary practice is UMiami Medicine - Neurology in Miami, Florida. Dr. Smirnoff is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Smirnoff to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smirnoff practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Smirnoff's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Smirnoff is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Smirnoff's licenses on file in 2 states: Florida and California.

Dmand AI lists cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, hypersomnia and migraine and chronic headache among the conditions Dr. Smirnoff treats.

CMS data shows 55 Medicare services from Dr. Smirnoff across 3 procedure codes in 2024, for 79 Medicare patients. Medicare paid $5,742 for them.

CMS counts 79 Medicare patients who saw Dr. Smirnoff in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smirnoff's median patient age at 55, with 71% women.

In 2024, Dr. Smirnoff wrote 282 Medicare Part D claims for 51 patients. 71% of them were for generic drugs. CMS names the drug for 132 of them, across 7 drugs with 11 or more claims each, at $33,331 in total drug cost. In 2023, CMS named 57 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Smirnoff for performance year 2024, reported as part of a group. Dr. Smirnoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smirnoff as offering telehealth.

Dmand AI links 8 papers to Dr. Smirnoff, published from 2022 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Migraine Disorders, Electric Stimulation Therapy and Headache. Dr. Smirnoff has published most often in Curr Pain Headache Rep. Dr. Smirnoff's most frequent co-authors are Hector F. Bonilla, MD, Michelle Bravo, MD and Alexandra Nicole Cocores, MD.

CMS Open Payments shows 58 general payments to Dr. Smirnoff from 14 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 71% of the total. Impel Pharmaceuticals Inc. paid the most, $11,697.

Dr. Smirnoff graduated from FIU Herbert Wertheim College of Medicine in 2016. Dr. Smirnoff is a member of AAN and AMA.

Dr. Smirnoff is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.